REGULATED PRESS RELEASE published on 12/02/2024 at 07:30, 1 year 4 months ago Gimv invests in the further growth and internationalization of Lupine Lighting Systems Gimv acquires majority stake in Lupine Lighting Systems for growth and internationalization. Lupine, a 'Made in Germany' brand leader, focuses on premium portable light solutions for (e-)bike, outdoor, and tactical applications Gimv Investment Growth Internationalization Lupine Lighting Systems
BRIEF published on 11/21/2024 at 07:03, 1 year 4 months ago Gimv Reports 9.4% Increase in Net Asset Value per Share Financial Results Investment Strategy Net Asset Value Gimv Portfolio Growth
REGULATED PRESS RELEASE published on 11/21/2024 at 06:58, 1 year 4 months ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio Net Asset Value per share increases by 9.4% to EUR 55.6 in six months driven by strong portfolio growth and profit. Potential capital increase planned for growth acceleration Net Asset Value Capital Increase Portfolio Growth Profit Growth Acceleration
BRIEF published on 11/20/2024 at 07:50, 1 year 4 months ago Gimv Sells Major Stake in Rehaneo to Fremman Capital Gimv Rehaneo Fremman Capital Outpatient Rehabilitation Investment Transaction
REGULATED PRESS RELEASE published on 11/20/2024 at 07:45, 1 year 4 months ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo Fremman Capital acquires majority stake in outpatient rehabilitation specialist rehaneo from Gimv. Rehaneo aims to become a European leader in outpatient rehabilitation sector Gimv European Leader Rehaneo Fremman Capital Outpatient Rehabilitation
BRIEF published on 10/28/2024 at 17:50, 1 year 5 months ago Gimv Invests in Kivu Bioscience's $92M Series A Funding Oncology Series A ADC Funding Gimv Investment Kivu Bioscience
REGULATED PRESS RELEASE published on 10/28/2024 at 17:45, 1 year 5 months ago Gimv participates in a $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates Gimv participates in $92M Series A financing round at Kivu Bioscience to advance next-gen antibody-drug conjugates. Novo Holdings leads the round Gimv Antibody-drug Conjugates Series A Kivu Bioscience Novo Holdings
BRIEF published on 10/16/2024 at 07:50, 1 year 6 months ago Brouwerij Martens Acquires United Dutch Breweries for Global Expansion Acquisition Innovation Global Expansion Sustainability Brewing Industry
REGULATED PRESS RELEASE published on 10/16/2024 at 07:45, 1 year 6 months ago Brouwerij Martens acquires United Dutch Breweries with a purpose of further joint global expansion Brouwerij Martens acquires United Dutch Breweries for joint global expansion. The acquisition aims to leverage each company's strengths for further growth and value creation Acquisition Global Expansion Brouwerij Martens United Dutch Breweries Brewery
BRIEF published on 09/19/2024 at 17:50, 1 year 6 months ago Gimv Sells Half of Participation in Infravest to WorxInvest Corporate Transaction WorxInvest Gimv Infravest Belgian Companies Code European Infrastructure
Published on 04/17/2026 at 09:01, 52 minutes ago Apex Critical Metals Included in Newly Launched Sprott Rare Earths ETF
Published on 04/17/2026 at 08:00, 1 hour 53 minutes ago Caledonia Mining Corporation Plc - Dividend Payment Date for the Holders of Depositary Interests Representing Shares Trading on AIM
Published on 04/17/2026 at 02:13, 7 hours 40 minutes ago CHAR Tech annonce l’acquisition projetée d’actifs de biocarbone au Québec, incluant un accord d’achat de 62 500 tonnes, une installation et de la propriété intellectuelle
Published on 04/17/2026 at 02:00, 7 hours 53 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 10 hours 21 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/17/2026 at 09:45, 8 minutes ago AUSTRIACARD HOLDINGS AG: Disposal of minority shareholding in SEGLAN S.L. for a total cash consideration of €2.25m
Published on 04/17/2026 at 09:38, 15 minutes ago Heidelberg Pharma Announces Change in Executive Board
Published on 04/17/2026 at 09:00, 52 minutes ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY
Published on 04/17/2026 at 09:10, 43 minutes ago Number of shares and voting rights - March 2026 (In French only)
Published on 04/16/2026 at 18:02, 15 hours 51 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 15 hours 59 minutes ago Aéroports de Paris S.A - March 2026 traffic figures